BIOFORCE NANOSCIENCES HOLDINGS, INC. Stockholders Equity

Quick Answer

BIOFORCE NANOSCIENCES HOLDINGS, INC. reported Stockholders Equity of -$2.30 million for fiscal year 2024.

BIOFORCE NANOSCIENCES HOLDINGS, INC. Stockholders Equity — Annual History

Fiscal Year Stockholders Equity YoY Change
2024 -$2.30M -26.5%
2023 -$1.82M -35.0%
2022 -$1.35M -56.3%
2021 -$861.9K -139.5%
2020 -$359.9K -860.8%
2019 $47.3K +58.7%
2018 $29.8K +263.4%
2017 $8.2K +258.9%
2016 $2.3K

Quarterly Stockholders Equity

Quarter Ending Stockholders Equity YoY QoQ
September 30, 2025 -$499.9K +77.1% -30.2%
June 30, 2025 -$384.0K +81.4% -47.0%
March 31, 2025 -$261.2K +86.6% +88.6%
December 31, 2024 -$2.30M -26.5% -5.7%
September 30, 2024 -$2.18M -27.8% -5.5%
June 30, 2024 -$2.06M -29.7% -5.9%
March 31, 2024 -$1.95M -32.0% -7.2%
December 31, 2023 -$1.82M -35.0% -6.7%
  • BIOFORCE NANOSCIENCES HOLDINGS, INC. showed a decrease of -26.5% in Stockholders Equity compared to the prior fiscal year.
  • Over the 2016–2024 period, BIOFORCE NANOSCIENCES HOLDINGS, INC.’s stockholders equity has declined by 100826.1% (from $2.3 thousand to -$2.30 million).
  • The most recent figure is from BIOFORCE NANOSCIENCES HOLDINGS, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 8, 2025.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment